Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore aliqua. Mauris a diam maecenas sed. Ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel.
Purus in mollis nunc sed id semper risus. Congue quisque egestas diam in. Volutpat consequat mauris nunc congue nisi vitae suscipit tellus mauris. Neque volutpat ac tincidunt vitae semper quis lectus nulla at. Dignissim cras tincidunt lobortis feugiat vivamus at augue. Odio tempor orci dapibus ultrices in iaculis. Id neque aliquam vestibulum morbi blandit cursus risus at ultrices. Odio tempor orci dapibus ultrices in iaculis nunc sed augue. Amet nisl suscipit adipiscing bibendum est ultricies.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris a diam maecenas sed. Ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Join us on October 7 and 8 for this dynamic, interactive meeting focused on the latest basic science, translational, and clinical research in kidney cancer.
It’s one of the most exciting things I’ve ever participated in. We’re bringing together clinicians, physician scientists, and bench scientists to talk about kidney cancer research. The goal is to invigorate the science and spur breakthroughs.
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula. Pellentesque in ipsum id
Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula. Pellentesque in ipsum id
KidneyCAN joins nearly 200 other patient advocacy, public health, and health care professional organizations signing on to a letter from the American Cancer Society endorsing strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). This was...
KidneyCAN Program Director, Melissa Derr, is on the Hill today visiting congressional offices before the House Defense Appropriations bill is drafted. We are reminding key offices of our FY27 request: restore funding for the Kidney Cancer Research Program to $50...
KidneyCAN joins nearly 200 other patient advocacy, public health, and health care professional organizations signing on to a letter from the American Cancer Society endorsing strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). This was...
KidneyCAN Program Director, Melissa Derr, is on the Hill today visiting congressional offices before the House Defense Appropriations bill is drafted. We are reminding key offices of our FY27 request: restore funding for the Kidney Cancer Research Program to $50...
KidneyCAN advocate, team lead, and US Veteran, Bruce Hill, speaks at a Congressional briefing hosted by CDMRP Director Colonel Hartell. This briefing gives a CDMRP overview, discusses organizational priorities, and highlights research accomplishments. Bruce speaks...
Join Us!
Error: No connected account.
Please go to the Instagram Feed settings page to connect an account.
The Kidney Cancer Coalition is a US public charity (EIN #81-3352468), recognized by the Internal Revenue Service as exempt from Federal tax under Section 501 (C)(3) of the tax code. Donors should consult their tax advisor to determine whether they are eligible to claim a deduction associated with their donation.
